ROHTO PHARMACEUTICAL CO.,LTD. Logo

ROHTO PHARMACEUTICAL CO.,LTD.

Manufactures OTC drugs, skincare, and cosmetics with a focus on eye and dermatological health.

4527 | T

Overview

Corporate Details

ISIN(s):
JP3982400008
LEI:
Country:
Japan
Address:
大阪市生野区巽西1丁目8番1号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Rohto Pharmaceutical Co., Ltd. is a multinational company that manufactures and markets pharmaceutical products, cosmetics, and functional foods. Its core business centers on over-the-counter (OTC) drugs and skincare, with a significant focus on eye care and dermatological products. The company's portfolio includes a wide range of health and beauty care items. Committed to innovation, Rohto actively engages in research and development, conducting clinical trials for new therapeutic agents and leveraging advanced technologies to develop novel health solutions. The company's mission is to support the physical and mental health of people worldwide, contributing to the overall well-being of individuals and society.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-14 02:50
Interim Report
確認書
Japanese 9.3 KB
2025-11-14 02:48
Interim Report
半期報告書-第90期(2025/04/01-2026/03/31)
Japanese 282.3 KB
2025-07-11 04:04
Registration Form
訂正確認書
Japanese 9.3 KB
2025-07-11 04:03
Annual Report
訂正有価証券報告書-第89期(2024/04/01-2025/03/31)
Japanese 1.1 MB
2025-07-01 02:29
Regulatory News Service
臨時報告書
Japanese 30.2 KB
2025-06-25 02:08
Governance Information
内部統制報告書-第89期(2024/04/01-2025/03/31)
Japanese 26.7 KB
2025-06-25 02:07
Registration Form
有価証券報告書-第89期(2024/04/01-2025/03/31)
Japanese 1.9 MB
2025-06-25 02:07
Registration Form
確認書
Japanese 9.4 KB
2025-05-12 03:40
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 23.0 KB
2025-04-14 02:15
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 23.0 KB
2025-03-14 01:44
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 24.1 KB
2025-02-27 03:52
Share Issue/Capital Change
訂正臨時報告書
Japanese 37.8 KB
2025-02-26 08:00
Share Issue/Capital Change
臨時報告書
Japanese 44.8 KB
2025-02-13 02:46
Major Shareholding Notification
大量保有報告書
Japanese 38.2 KB
2024-11-14 02:17
Interim Report
確認書
Japanese 9.5 KB

Automate Your Workflow. Get a real-time feed of all ROHTO PHARMACEUTICAL CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ROHTO PHARMACEUTICAL CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ROHTO PHARMACEUTICAL CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France
ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden
ABLI
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapies for oncology & ophthalmology.
United States of America
ABP
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France
AB
ACADIA PHARMACEUTICALS INC Logo
Develops and commercializes innovative therapies for CNS disorders and rare diseases.
United States of America
ACAD
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
Developing cytisinicline, a plant-based treatment for smoking cessation and nicotine addiction.
United States of America
ACHV
AC Immune SA Logo
Developing precision medicine to diagnose, treat, and prevent neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
A clinical-stage biopharma developing novel drugs for immuno-inflammatory diseases.
United States of America
ACRS
Actinium Pharmaceuticals, Inc. Logo
Develops targeted radiotherapies for advanced cancers like AML and prostate cancer.
United States of America
ATNM

Talk to a Data Expert

Have a question? We'll get back to you promptly.